NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX:
Post# of 87
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its portfolio company, Radicle Medical Marijuana Inc., has received approval for oil sales from Health Canada. The additional license allows for the development and sale of new cannabis products, including oil and concentrates, which will open the door for Radicle’s medical patients to access other product forms in the company’s craft cannabis selection. “Consumer behaviors are evolving, and we believe many of today’s cannabis consumers are open to trying alternatives to dried flower products,” Canopy Rivers President and CEO Narbé Alexandrian said in the news release. “With its Health Canada approval for the sale of formulated oil products, Radicle is well positioned to capitalize on this demand while maintaining its commitment to the production of premium, small-batch craft cannabis.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer